Literature DB >> 24109245

Intracameral injection of tissue plasminogen activator to treat severe postoperative fibrinous reaction in iridocorneal endothelial syndrome.

Bryan K Hong1, Brian A Francis.   

Abstract

Iridocorneal endothelial (ICE) syndrome is a primary endothelial abnormality that can cause a spectrum of iris changes, corneal edema, and glaucoma. Glaucoma secondary to ICE is difficult to manage because of the inflammatory reaction and fibrosis it can cause. We present a case of postoperative fibrinous reaction following endoscopic cyclophotocoagulation in ICE that caused aqueous tube shunt occlusion and high intraocular pressure. The condition was successfully managed with tissue plasminogen activator.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24109245      PMCID: PMC3790595          DOI: 10.5693/djo.02.2013.02.002

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  6 in total

1.  Endoscopic cyclophotocoagulation (ECP) in the management of uncontrolled glaucoma with prior aqueous tube shunt.

Authors:  Brian Alan Francis; A Shahem Kawji; Nguyen Thao Vo; Laurie Dustin; Vikas Chopra
Journal:  J Glaucoma       Date:  2011-10       Impact factor: 2.503

2.  Long-term outcome of aqueous shunt surgery in ten patients with iridocorneal endothelial syndrome.

Authors:  D K Kim; I M Aslanides; C M Schmidt; G L Spaeth; R P Wilson; J J Augsburger
Journal:  Ophthalmology       Date:  1999-05       Impact factor: 12.079

3.  A comparison of the clinical variations of the iridocorneal endothelial syndrome.

Authors:  M C Wilson; M B Shields
Journal:  Arch Ophthalmol       Date:  1989-10

4.  Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.

Authors:  E A Doe; D L Budenz; S J Gedde; N R Imami
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

5.  Glaucoma and the iridocorneal endothelial syndrome.

Authors:  H C Laganowski; M G Kerr Muir; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1992-03

6.  Intracameral tissue plasminogen activator after glaucoma surgery. Indications, effectiveness, and complications.

Authors:  D C Lundy; P Sidoti; T Winarko; D Minckler; D K Heuer
Journal:  Ophthalmology       Date:  1996-02       Impact factor: 12.079

  6 in total
  2 in total

1.  ICE SYNDROME--CASE REPORT.

Authors:  Valeria Coviltir; Dinu Valentin
Journal:  Rom J Ophthalmol       Date:  2015 Apr-Jun

2.  Successful pediatric DMEK facilitated by intracameral tissue plasminogen activator to mitigate anterior chamber fibrin reaction.

Authors:  Tanner J Ferguson; Elias I Traboulsi; Jeffrey M Goshe
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.